Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 21, 2017; 23(3): 540-546
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.540
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.540
Figure 1 Schedule of the chemoradiotherapy protocol.
LCAF radiotherapy consisted of 41.4 Gy (1.8 Gy/fraction, q.d.) using large fields, and 27 Gy (1.5 Gy/fraction, b.i.d.) using reduced fields, with a total dose of 68.4 Gy/41 fractions in 44 d. CF radiotherapy consisted of 61.2 Gy/34 fractions in 48 d (1.8 Gy/fraction, q.d.). The chemotherapy regimen included PTX at 175 mg/m2, D1 and DDP at 25 mg/m2, D1-3. RT: radiotherapy; LCAF: late-course accelerated radiotherapy; CF: conventional radiotherapy; CT: Computed tomography; DDP: Cisplatin; PTX: Paclitaxel.
- Citation: Zhu HT, Ai DS, Tang HR, Badakhshi H, Fan JH, Deng JY, Zhang JH, Chen Y, Zhang Z, Xia Y, Guo XM, Jiang GL, Zhao KL. Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma. World J Gastroenterol 2017; 23(3): 540-546
- URL: https://www.wjgnet.com/1007-9327/full/v23/i3/540.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i3.540